Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...
May 01, 2026 06:50 ET | Source: Research and Markets

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab and Etanercept Biosimilars Market Report 2026" has been added to ResearchAndMarkets.com's offering. The adalimumab,...
April 29, 2026 20:55 ET | Source: Mesoblast Limited

Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million

Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) --...
April 29, 2026 07:22 ET | Source: SNS Insider pvt ltd

Biologics Market Size is Poised to be USD 1,283.29 Billion by 2035; Growth is Propelling as it is an Essential Modern Healthcare Globally | SNS Insider

Biologics market grows strongly, driven by chronic diseases, innovation in gene therapies, and rising demand for targeted, effective treatments globally.
April 14, 2026 20:10 ET | Source: Mesoblast Limited

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired...
April 13, 2026 07:00 ET | Source: Soleo Health Holdings, Inc.

Soleo Health Opens New Ambulatory Infusion Center in Louisville, Kentucky

FRISCO, Texas and LOUISVILLE, Ky., April 13, 2026 (GLOBE NEWSWIRE) -- Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its new ambulatory...
April 10, 2026 04:43 ET | Source: Research and Markets

Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease: Eight-Market Drug Forecast and Market Analysis - Update (2025)" report has been added to ResearchAndMarkets.com's offering.This...
April 09, 2026 10:10 ET | Source: Research and Markets

UCB S.A. Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: UCB - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights...
April 07, 2026 07:00 ET | Source: Soleo Health Holdings, Inc.

Soleo Health Relocates Denver Specialty Pharmacy to Support Continued Growth

FRISCO, Texas and CENTENNIAL, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening...
April 02, 2026 11:00 ET | Source: Crohn's and Colitis Canada

Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026

TORONTO, 02 avr. 2026 (GLOBE NEWSWIRE) -- Crohn et Colite Canada et AbbVie sont heureux d'annoncer l'ouverture des candidatures pour le Programme de bourses d'études MII d’AbbVie 2026. Cette année...